Target General Information |
Target ID |
T31595
|
Target Name |
Influenza Neuraminidase (NA) |
Gene Name |
NA |
Species |
Influenza A viruses H1N1 |
UniProt ID |
C3W5Y1_9INFA |
Sequence |
MNPNQKIITIGSVCMTIGMANLILQIGNIISIWISHSIQLGNQNQIETCNQSVITYENNT WVNQTYVNISNTNFAAGQSVVSVKLAGNSSLCPVSGWAIYSKDNSVRIGSKGDVFVIREP FISCSPLECRTFFLTQGALLNDKHSNGTIKDRSPYRTLMSCPIGEVPSPYNSRFESVAWS ASACHDGINWLTIGISGPDNGAVAVLKYNGIITDTIKSWRNNILRTQESECACVNGSCFT VMTDGPSNGQASYKIFRIEKGKIVKSVEMNAPNYHYEECSCYPDSSEITCVCRDNWHGSN RPWVSFNQNLEYQIGYICSGIFGDNPRPNDKTGSCGPVSSNGANGVKGFSFKYGNGVWIG RTKSISSRNGFEMIWDPNGWTGTDNNFSIKQDIVGINEWSGYSGSFVQHPELTGLDCIRP CFWVELIRGRPKENTIWTSGSSISFCGVNSDTVGWSWPDGAELPFTIDK [Influenza A viruses H1N1]
|
Drug and Corresponding Resistance Mutations |
Mutation Info |
Missense: E119G |
Drugs |
Drug Name |
Zanamivir |
Drug Info
|
[1] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Zanamivir |
Drug Info
|
[1] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Peramivir |
Drug Info
|
[1] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Oseltamivir |
Drug Info
|
[1] |
Targeted Disease |
Influenza virus infection |
|
Mutation Info |
Missense: H275Y |
Drugs |
Drug Name |
Oseltamivir |
Drug Info
|
[3] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Amantadine |
Drug Info
|
[3] |
Targeted Disease |
Influenza virus infection |
|
Mutation Info |
Missense: R118P |
Drugs |
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
Mutation Info |
Missense: R292K |
Drugs |
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
Mutation Info |
Missense: R292W |
Drugs |
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
Drug Name |
Zanamivir |
Drug Info
|
[2] |
Targeted Disease |
Influenza virus infection |
|
References |
REF 1 |
Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations. Antiviral Res. 2013 Nov;100(2):356-64.
|
REF 2 |
Computational assay of Zanamivir binding affinity with original and mutant influenza neuraminidase 9 using molecular docking. J Theor Biol. 2015 Nov 21;385:31-9.
|
REF 3 |
Design and expeditious synthesis of organosilanes as potent antivirals targeting multidrug-resistant influenza A viruses. Eur J Med Chem. 2017 Jul 28;135:70-76.
|